KBIO - HUMANIGEN INC COM USD0.001

Other OTC - Other OTC Delayed Price. Currency in USD
2.19
+0.46 (+26.81%)
At close: 3:38PM EDT
Stock chart is not supported by your current browser
Previous Close1.73
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire10 months ago

    JGR Capital Partners Initiates Coverage on KaloBios Pharmaceuticals Inc.

    NEW YORK, NY / ACCESSWIRE / May 2, 2017 / JGR Capital Partners, a leading equity research and digital investor relations firm, has announced it has initiated coverage on KaloBios (OTC PINK: KBIO) with ...

  • Forbes11 months ago

    Rare Diseases Patients Need More Than Miracles And Trumpcare

    Rare Disease Week was rapidly followed by more proposals to gut the ACA healthcare and the FDA, immigration and travel bans which will decimate research and healthcare (as well as being needless and cruel), and reduce research budgets. How does this help patients?

  • We're sorry this is all we were able to find about this topic.